2 not yet recruiting, 1 completed, 1 terminated, 1 unknown. 4 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Not yet recruiting 2, Completed 1, Unknown 1 |
| Not applicable | 1 | Withdrawn 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Cervical Intraepithelial Neoplasia Grade 3: new trials by email Literature Review of Cervical Intraepithelial Neoplasia Grade 3 trials Research Report on Cervical Intraepithelial Neoplasia Grade 3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploratory Study of the Efficacy of HAL-PDT in CIN 3 Hexaminolevulinate (HAL) - Cervical Intraepithelial Neoplasia Grade 3 | Phase 2 | Not yet recruiting | Tongji Hospital | 260 | 2026-11-01 | 2026-10-23 |
| Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya 5% 5-fluorouracil Topical Cream, Placebo Cream - HIV Infections, HPV Infection | Phase 2 | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 140 | 2026-09-01 | 2026-08-27 |
| Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II Vvax001 therapeutic cancer vaccine - CIN3, Cervical Intraepithelial Neoplasia | Phase 2 | Unknown | University Medical Center Groningen | 18 | 2021-03-23 | 2023-08-29 |
| Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia HspE7, therapeutic conventional surgery, laboratory biomarker analysis - Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 3 | Phase 2 | Completed | National Cancer Institute (NCI) | 84 | 2004-06-01 | 2013-01-24 |
| Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia motexafin lutetium, photodynamic therapy, loop electrosurgical excision procedure - Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 2 | Phase 1 | Terminated | National Cancer Institute (NCI) | 54 | 2000-12-01 | 2013-02-07 |
| Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer colposcopy, cervical Papanicolaou test, screening method - Cervical Intraepithelial Neoplasia Grade 1, Cervical Intraepithelial Neoplasia Grade 2 | Not applicable | Withdrawn | Northwestern University | 2012-06-11 |
Uterine Cervical Dysplasia (6) · Uterine Cervical Neoplasms (4) · Papillomavirus Infections (2) · HIV Infections (1) · Vaginal Neoplasms (1) · Vulvar Neoplasms (1)
Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Genital Diseases (6) · Genital Diseases, Female (6) · Neoplasms (6) · Precancerous Conditions (6) · Urogenital Diseases (6) · Uterine Cervical Diseases (6) · Uterine Diseases (6) · Genital Neoplasms, Female (4) · Neoplasms by Site (4) · Urogenital Neoplasms (4) · Uterine Neoplasms (4) · Communicable Diseases (2) · DNA Virus Infections (2)
1-phenyl-3,3-dimethyltriazene (1) · 5-aminolevulinic acid hexyl ester (1) · Colposcopy (1) · High-Throughput Screening Assays (1) · Photochemotherapy (1) · Vaginal Smears (1) · motexafin lutetium (1)
National Cancer Institute (NCI) (2) · Northwestern University (1) · Tongji Hospital (1) · UNC Lineberger Comprehensive Cancer Center (1) · University Medical Center Groningen (1)
United States (2) · China (1) · Kenya (1) · Netherlands (1)
Amy Halverson (1) · Chemtai Mungo, MD, MPH (1) · Cornelia Trimble (1) · John Comerci (1)
R37CA306827 (1), U01CA099168 (1), U10CA027469 (1)